HUP9800521A3 - Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or propylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis - Google Patents

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or propylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis

Info

Publication number: HUP9800521A3
Authority: HU; Hungary
Prior art keywords: propylaxis; hyperlipoproteinaemia; hypertriglyceridaemia; hypercholesterolaemia; hyperlipidaemia
Prior art date: 1995-01-13

Application number

HU9800521A

Other languages

Hungarian (hu)

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-01-13

Filing date

1996-01-10

Publication date

1999-12-28

1996-01-10 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

1998-12-28 Publication of HUP9800521A2 publication Critical patent/HUP9800521A2/en

1999-12-28 Publication of HUP9800521A3 publication Critical patent/HUP9800521A3/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Obesity (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyrane Compounds (AREA)

HU9800521A 1995-01-13 1996-01-10 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or propylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis HUP9800521A3 (en)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
DK4395		1995-01-13
DK4195		1995-01-13
DK6995		1995-01-20
DK76695		1995-06-30
DK76795		1995-06-30
DK77795		1995-06-30

Publications (2)

Publication Number	Publication Date
HUP9800521A2 HUP9800521A2 (en)	1998-12-28
HUP9800521A3 true HUP9800521A3 (en)	1999-12-28

Family

ID=27545138

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU9800521A HUP9800521A3 (en)	1995-01-13	1996-01-10	Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or propylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis

Country Status (11)

Country	Link
EP (1)	EP0804189A1 (en)
JP (1)	JPH10511961A (en)
CN (1)	CN1168098A (en)
AU (1)	AU4329296A (en)
BR (1)	BR9606890A (en)
CA (1)	CA2208859A1 (en)
CZ (1)	CZ212397A3 (en)
HU (1)	HUP9800521A3 (en)
IL (1)	IL116745A (en)
NO (1)	NO973241D0 (en)
WO (1)	WO1996021443A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5407955A (en) *	1994-02-18	1995-04-18	Eli Lilly And Company	Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
US6069175A (en) *	1996-11-15	2000-05-30	Pfizer Inc.	Estrogen agonist/antagonists treatment of atherosclerosis
WO1999048497A1 (en) *	1998-03-20	1999-09-30	Novo Nordisk A/S	USE OF 3,4-DIPHENYLCHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR LOWERING PLASMA LEVELS OF Lp(a) IN A HUMAN OR SUB-HUMAN PRIMATE
US7005428B1 (en)	1998-06-11	2006-02-28	Endorecherche, Inc.	Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en)	1998-06-11	2002-10-15	Endorecherche, Inc.	Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6613083B2 (en)	2001-05-02	2003-09-02	Eckhard Alt	Stent device and method
US8080675B2 (en)	2004-09-21	2011-12-20	Marshall Edwards, Inc.	Chroman derivatives, medicaments and use in therapy
EP1794141B1 (en)	2004-09-21	2011-11-09	Marshall Edwards, Inc.	Substituted chroman derivatives, medicaments and use in therapy
US9708283B2 (en)	2010-11-01	2017-07-18	Mei Pharma, Inc.	Isoflavonoid compositions and methods for the treatment of cancer
SI2953938T1 (en)	2014-02-07	2018-01-31	Novogen Ltd.	Functionalised benzopyran compounds and use thereof
CN116139125A (en)	2015-02-02	2023-05-23	梅制药公司	combination therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1543749A1 (en) *	1966-02-16	1969-12-11	Merck Ag E	Process for the preparation of 3,4-cis-4-aryl-isoflavans
US5407955A (en) *	1994-02-18	1995-04-18	Eli Lilly And Company	Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

1996
- 1996-01-10 CZ CZ972123A patent/CZ212397A3/en unknown
- 1996-01-10 BR BR9606890A patent/BR9606890A/en not_active Application Discontinuation
- 1996-01-10 CN CN96191417A patent/CN1168098A/en active Pending
- 1996-01-10 WO PCT/DK1996/000014 patent/WO1996021443A1/en not_active Ceased
- 1996-01-10 EP EP96900095A patent/EP0804189A1/en not_active Withdrawn
- 1996-01-10 HU HU9800521A patent/HUP9800521A3/en unknown
- 1996-01-10 CA CA002208859A patent/CA2208859A1/en not_active Abandoned
- 1996-01-10 AU AU43292/96A patent/AU4329296A/en not_active Abandoned
- 1996-01-10 JP JP8521377A patent/JPH10511961A/en active Pending
- 1996-01-12 IL IL11674596A patent/IL116745A/en not_active IP Right Cessation
1997
- 1997-07-11 NO NO973241A patent/NO973241D0/en unknown

Also Published As

Publication number	Publication date
BR9606890A (en)	1997-10-28
AU4329296A (en)	1996-07-31
NO973241L (en)	1997-07-11
CA2208859A1 (en)	1996-07-18
MX9705214A (en)	1997-10-31
IL116745A (en)	1999-12-22
JPH10511961A (en)	1998-11-17
WO1996021443A1 (en)	1996-07-18
CN1168098A (en)	1997-12-17
EP0804189A1 (en)	1997-11-05
IL116745A0 (en)	1996-05-14
NO973241D0 (en)	1997-07-11
HUP9800521A2 (en)	1998-12-28
CZ212397A3 (en)	1997-11-12

Similar Documents

Publication	Publication Date	Title
CA2194167A1 (en)	1996-01-11	Hair-growing agent
CA2218714A1 (en)	1996-11-28	Dosage form comprising oxybutynin
ZA962854B (en)	1996-10-11	Emulsion suitable for administering a poorly water-soluble photosensitizing compound and use thereof
ZA965368B (en)	1997-01-14	A pharmaceutical formulation
AU6552398A (en)	1999-05-10	Testing the effectiveness of a sterilization procedure
ZA96124B (en)	1996-08-13	A pharmaceutical formulation
FI955691L (en)	1996-05-29	Lipoprotein(a)-lowering agent, cholesterol-lowering agent and medicines containing these agents
HUP9800521A3 (en)	1999-12-28	Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or propylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis
IL116746A0 (en)	1996-05-14	Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions
ZA958606B (en)	1996-05-14	A pharmaceutical formulation
AU7630296A (en)	1997-07-17	Compositions for the treatment of keratinic materials containing the association of a polyampholyte polymer and cationic polymer
IL116828A0 (en)	1996-05-14	Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
FR2736826B1 (en)	1997-08-22	FILTERING COMPOSITION FOR COSMETIC OR DERMATOLOGICAL USE
IL117629A0 (en)	1996-07-23	Pharmaceutical compositions containing a benzamide derivative and methods for the preparation thereof
PL326759A1 (en)	1998-10-26	Synergic composition of immunosupressants containing a 2,2'-bi-1h-pyrrole composition
HUP9800334A3 (en)	1999-12-28	Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity
ZA96251B (en)	1997-02-20	Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment.
ZA98681B (en)	1998-07-29	Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibition senescense-associated motor impairment
ZA964372B (en)	1996-12-05	A pharmaceutical formulation
HUP9800297A3 (en)	1999-12-28	Use of 3,4-diphenyl chromans for the manufacture of a vasodilatory pharmaceutical composition
AU5515196A (en)	1996-11-29	Laryngeal bactericidal and antiseptic composition
ZA965367B (en)	1997-01-23	A pharmaceutical formulation
AU3433997A (en)	1998-02-09	Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for lowering intraocular pressure
ZA98682B (en)	1998-07-29	Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more psychiatric disorders
ZA96122B (en)	1996-07-24	A pharmaceutical formulation